Related Experiment Videos
Angiogenesis in normal and neoplastic ovaries
S Ramakrishnan1, I V Subramanian, Y Yokoyama
1Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA. sunda001@umn.edu
Angiogenesis
|October 8, 2005
Summary
This review explores ovarian angiogenesis, focusing on how blood vessel formation supports ovarian cancer growth and spread. It highlights anti-angiogenic therapies as a promising treatment strategy for ovarian cancer.
Area of Science:
- Reproductive biology and oncology
- Molecular mechanisms of angiogenesis
- Ovarian cancer pathogenesis
Background:
- Ovarian physiology is regulated by hormones and involves angiogenesis.
- The ovary is a key model for studying blood vessel development and regression.
- Ovarian cancer, originating from ovarian epithelium, relies heavily on angiogenesis.
Purpose of the Study:
- To review recent findings on angiogenic responses in neoplastic ovaries.
- To discuss the role of angiogenesis in ovarian cancer development and dissemination.
- To explore the potential of anti-angiogenic therapies for ovarian cancer treatment.
Main Methods:
- Literature review of recent advances in ovarian angiogenesis and cancer research.
- Analysis of molecular mechanisms underlying angiogenesis in normal and cancerous ovaries.
- Evaluation of preclinical and clinical data on anti-angiogenic agents in ovarian cancer.
Main Results:
- Angiogenesis is crucial for ovarian cancer progression and metastasis.
- Specific molecular pathways regulate angiogenic activity in neoplastic ovaries.
- Anti-angiogenic strategies show promise in preclinical and clinical studies.
Conclusions:
- Understanding ovarian angiogenesis is key to developing effective ovarian cancer treatments.
- Targeting angiogenesis offers a viable therapeutic avenue for managing ovarian cancer.
- Further research into anti-angiogenic approaches is warranted for ovarian cancer therapy.